Clinical Trial

Study on the Diagnosis and Management of CLL in Italy by GIMEMA

Recruiting
View on ClinicalTrials.gov →
Summary
retrospective and prospective multicenter observational clinical and biological data collection from all patients with newly diagnosed CLL, SLL or MBL. retrospective cohort: all cases with a diagnosis between January 1st 2010 and August 31th 2021. prospective cohort: all patients with a diagnosis between September 1st 2021 and September 1st 2025.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-04-29; most recent amendment 2025-03-12.
Status change: Not Yet Recruiting → Recruiting 2022-01-03
Trial Details
NCT Number NCT04867915
Lead Sponsor Gruppo Italiano Malattie EMatologiche dell'Adulto
Conditions Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, MBL-CLL - Monoclonal B-Cell Lymphocytosis Chronic Lymphocytic Leukaemia-Type
Enrollment 12,500 participants
Start Date 2021-10-13
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2025-03-14